Skip to main content

New York

Public Health Trace has 23,332 recall records and 3,306 outbreak investigations on file connected to New York, with 107,237 reported illnesses across those outbreak investigations, republished from official FDA, USDA, and CDC sources.

23,332
Recalls distributed here
3,306
Outbreaks affecting this state
107,237
Reported illnesses
Recalls and outbreaks by year

A bar chart of recall and outbreak counts affecting this state by year, built from the complete yearly totals for this state, not a bounded preview.

  • Recalls
  • Outbreaks
Download CSV
View full recalls and outbreaks by year (56 years)
Recalls and outbreaks by year
YearRecallsOutbreaks
197101
197201
197300
197402
197500
197601
197700
197808
197901
198002
198102
198204
198300
198404
198503
198601
198700
198801
198906
199002
199100
199204
199301
199403
199506
199603
199705
1998074
1999056
2000065
2001060
2002054
2003043
2004064
2005063
2006083
2007055
2008058
20090290
20100337
20110336
2012396286
20131,152273
201472465
20151,743294
20161,876246
20172,439205
20181,62574
20192,73962
20201,32218
20211,12924
20222,17635
20232,29325
20241,3030
20251,2390
20261,1760

CDC NORS is a historical archive currently available through 2023; later zeros do not mean no outbreaks occurred.

Recall records distributed in New York

Newest reported records first. Each record's own status (active, terminated, or not reported) is shown on its card.

FDA Recall Ongoing2026 recordClass II

Apothecary NAD+ Injection 200 mg/mL, 6 mL Sterile Multi-Dose Vial, Rx Only, Apothecary Pharma, LLC, 1913 Evans Road, Cary, NC, 27513, NDC 85091-011-06.

by Apothecary Pharma LLC

Reason
Lack of Assurance of Sterility
Published
October 14, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

Tirzepatide Injection, 18mg/mL, 4 mL Sterile Multi-Dose Vial, Rx only, Apothecary Pharma, LLC, 1913 Evans Road, Cary, NC 27513, NDC 85091-001-18.

by Apothecary Pharma LLC

Reason
Lack of Assurance of Sterility
Published
October 14, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing2026 recordClass III

Tretinoin Cream UPS, 0.05%, 20g, Rx only, Mfd. by: Taro Pharmaceuticals Inc., Brampton, Ontario, Canada L6T 1C1, Dist. by: Taro Pharmaceuticals USA Inc., Hawthorne, NY 10532, NDC 51672-1394-0.

by SUN PHARMACEUTICAL INDUSTRIES INC

Reason
Failed Impurities/Degradation Specifications
Published
October 14, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing2026 recordClass III

Tretinoin Cream USP, 0.05%, 45 g tube, Manufactured for: Northstar Rx LLC, Memphis, TN 38141, Manufactured by: Taro Pharmaceuticals Inc., Brampton, Ontario, Canada L6T 1C1, Product of Canada, NDC 16714-249-02.

by SUN PHARMACEUTICAL INDUSTRIES INC

Reason
Failed Impurities/Degradation Specifications
Published
October 14, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing2026 recordClass III

Tretinoin Cream USP, 0.05%, 45g tube, Rx only, Mfd by: Taro Pharmaceuticals Inc., Brampton, Ontario, Canada L6T 1C1, Dist. by: Taro Pharmaceuticals USA Inc., Hawthorne, NY 10532, NDC 51672-1394-9.

by SUN PHARMACEUTICAL INDUSTRIES INC

Reason
Failed Impurities/Degradation Specifications
Published
October 14, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

Tri-MIX (PAPAV/PHENTO/ALPROS),30/2/40, Packaged in single-use dosage syringes, total mL dispensed based on dosage per specific patient prescription, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936

by Carolina Infusion, LLC

Reason
Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.
Published
October 14, 2026
Distribution
Nationwide

View recall →

Showing 6 of 23,332 recall records

See all recalls in New York

Outbreak records affecting New York

Newest reported records first. Each record's own status (active investigation, historical, or monitoring) is shown on its card.

Showing 6 of 3,306 outbreak records

See all outbreaks in New York

Companies with recalls distributed in New York

Via the real distribution-state record on each recall -- distinct from the free-text match used for the recall cards above.

CDC announcements naming New York

Only announcements with an explicit, normalized relationship to New York are shown -- see our methodology.

Disease surveillance trends

No disease surveillance trend data has been published for this state.

Data availability

Disease surveillance trends are only shown where CDC's reporting areas have been matched to this state. A state showing no surveillance data here may still have real recalls and outbreaks above - the gap is in state-level linkage for weekly case reports specifically, not an indication that nothing was reported.

Freshness unavailable for one or more included sources

This page combines recall records from the FDA and USDA with outbreak investigations and disease surveillance data from the CDC. It is not a safety ranking or comparison between states -- a higher count here can reflect more thorough reporting as much as more actual events, and is not a statement that New York is more or less safe than any other state. Read the full medical disclaimer.

Reconnecting to the server…

We lost the connection to the server.

Your session has expired.